Janssen Pharmaceuticals Inc.

12/05/2021 | Press release | Distributed by Public on 12/05/2021 22:58

Johnson & Johnson COVID-19 Booster, Administered Six Months After Two-Dose Regimen of BNT162b2, Shows Substantial Increase in Antibody and T-cell Responses